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Abstract 
The aim of this work was to investigate the feasibility of cross-linker free polyelectrolyte 1 
complex formation at the nanoscale between carrageenan (CAR) and protamine (PROT). 2 
The properties of CAR/PROT nanoparticles (NPs) were dependent on the carrageenan type: 3 
kappa (KC), iota (IC) and lambda (LC), concentration of components, addition of divalent 4 
cations, weight mixing ratio (WMR) of constituents and mode of component addition. In the 5 
case of 0.1% w/v solutions, IC-based NPs had the smallest particle sizes (100-150 nm) and 6 
low polydispersity indices (0.1-0.4). A decrease in the solution concentration from 0.1% to 7 
0.05% w/v enabled the formation of KC/PROT NPs. All carrageenans exhibited the ability to 8 
form NPs with surface charge ranging from -190 to 40 mV. The inclusion of divalent cations 9 
caused an increase in the particle size and zeta potential. Infrared analysis confirmed the 10 
presence of a complex between CAR and PROT and showed that IC chains undergo 11 
structural changes when forming NPs. Colloidal stability of NPs was related to the initial 12 
surface charge of particles and was time- and pH-dependent. IC was found to be the most 13 
suitable type of CAR when forming nanoplexes with PROT. 14 
 15 
Keywords: Carrageenan; Protamine; Nanoparticles; Polyelectrolyte Complexes; Dynamic 16 
Light Scattering; Infrared spectroscopy   17 
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1. Introduction 18 
Recent advances in pharmaceutical nanotechnology are focused on using polymeric 19 
nanoparticulate systems as carriers for drugs (Delie & Blanco-Prieto, 2005). Nanoparticles 20 
(NPs) formulated from natural polymers have attracted considerable interest (Hans & 21 
Lowman, 2002). NPs have many advantages, such as the potential to retain protein stability, 22 
increase duration of therapeutic effects of proteins and they can be administered by 23 
nonparenteral routes (Sarmento, Bibeiro, Veiga, Ferreira and Neufeld, 2007). Natural 24 
polymers extensively studied for drug delivery purposes include polysaccharides such as 25 
alginate, chitosan, carrageenan (CAR) and proteins, for example casein and gelatin (Sonia & 26 
Sharma, 2012).  27 
Polymers, especially those of natural origin, are often composed of subunits capable of 28 
bearing charge, thus the polyelectrolyte complexation method of NP preparation has 29 
received increasing attention in recent years. NPs formed by this method have several 30 
characteristic advantages for cellular uptake and colloidal stability, including suitable 31 
diameter, surface charge, spherical morphologies and low polydispersity indices (Bayat et 32 
al., 2008). Furthermore, the preparation of NPs by polyelectrolyte complexation methods can 33 
be carried out in completely aqueous conditions and at ambient temperature; therefore the 34 
stability and biological activity of loaded peptides would not be affected (Hu, Yang and Hu, 35 
2012; Ryan et al., 2013; Umerska et al., 2012, 2014). 36 
Carrageenans (CARs) are an example of such polymers and are capable of forming 37 
polyanions. They are a family of hydrophilic sulphated biopolysaccharides extracted from 38 
various species of the Rhodophyta class of red seaweeds (Campo, Kawano, Braz da Silva 39 
and Carvalho, 2009). CARs are composed of a hydrophilic linear sulphated backbone of 40 
alternating 1→3 glycosidic-linked β-D-galactopyransose units and 1→4 glycosidic-linked α-D-41 
galactopyranose units or 1→4 glycosidic-linked 3, 6-anhydro-α-D-galactopyranose units 42 
(Figure 1) (Berth, Vukovic and Lechner, 2008) and principally differ in the number and 43 
position of the sulphate groups, however these reflect only general differences in the 44 
composition and degree of sulphation (Necas & Bartosikova, 2013). The actual content of the 45 
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sulphate residue (by weight) may vary between 15 and 40% for the various carrageenan types 46 
(Nanaki, Karavas, Kalantzi and Bikiaris, 2010). Their applications include experimental 47 
medicine, pharmaceutical formulations and are well established as gelling, stabilising and 48 
thickening agents for food, cosmetics and industrial uses (Necas & Bartosikova, 2013). 49 
CARs are biocompatible and biodegradable polysaccharides with low toxicity and well 50 
documented properties of controlling and extending release of various drug substances 51 
(Nanaki et al., 2010) as well as improving apparent solubility and dissolution rates of poorly 52 
soluble actives (Dai, Dong and Song, 2007). In addition, studies have shown that CARs 53 
have a high capacity to interact with proteins due to their strong ionic nature (Malafaya, Silva 54 
and Reis, 2007) and form excellent matrices for predictable synthesis of magnetite 55 
nanoparticles (Daniel-da-Silva et al., 2007). 56 
To form polyelectrolyte complexes (PECs) with CAR, protamine (PROT) was selected due to 57 
its reported in vitro membrane-translocating ability, believed to be associated with its positively 58 
charged polyarginine chains (Reynolds, Weissleder and Josephson, 2005). The use of cell-59 
penetrating peptides for drug delivery has been extensively studied over the past two 60 
decades (Temsamani & Vidal, 2004).  61 
Shumilina and Shchipunov (2002) investigated interactions between CAR and chitosan (CS). 62 
They showed that the nature or type of CAR considerably influenced the characteristics of 63 
the PECs. The mechanical strength of PEC gels were ranked as follows:  lambda 64 
carrageenan (LC)/CS > iota carrageenan (IC)/CS > kappa carrageenan (KC)/CS. Moreover, 65 
the gels obtained with IC and KC were temperature sensitive due to the helix-coil 66 
conformational transitions in their molecules (Shumilina & Shchipunov, 2002). An 67 
investigation was performed on the potential of PECs formed between KC, IC or LC and CS 68 
to form controlled release systems for glucose oxidase (Briones & Sato, 2010). The complex 69 
between CS and KC showed high encapsulation efficiencies for glucose oxidase while 70 
having the lowest release rate for this compound. Furthermore, this complex was able to 71 
protect the encapsulated glucose oxidase against degradation in pH 1.2 solution, in a 72 
chitosanase solution and in a pepsin solution (Briones & Sato, 2010). Another example of 73 
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CS/CAR PECs used for delivery of proteins has been reported (Li, Hein and Wang, 2013). 74 
As characterised by Li et al. (2013), in acidic solution the negatively charged sulphate 75 
groups of KC bound to positively charged amino groups of CS and formed acid-base PECs. 76 
When the pH was increased, amino groups protonated and the binding activity between both 77 
components became weaker, which resulted in swelling and disintegration of PEC and finally 78 
release of the protein. Modulation of drug release to the target site was possible by adjusting 79 
the factors that cause swelling properties of PEC (Li et al., 2013).  80 
A number of publications show that carrageenans complex to CS (Briones & Sato, 2010; Li 81 
et al. 2013; Shumilina & Shchipunov, 2002), however no work has been published to date 82 
which indicates whether complexation between CAR and PROT is possible. Previous work 83 
by Umerska et al. (2014) showed that PROT/hyaluronate PECs can form, at the nanoscale, 84 
but depending on the ratio of constituents in such PECs their colloidal stability varies 85 
considerably. Therefore in this study we have focused on CAR/PROT systems with the aim 86 
of undertaking a methodical assessment of the various types of CAR, their concentration, 87 
weight mixing ratios, mode of preparation and the additional small cation addition during 88 
PECs formation to investigate if CAR/PROT nanoplexes can be obtained and to determine 89 
the characteristics of any such nanoplexes formed. CAR/PROT nanoplexes have the 90 
potential of being biocompatible, safe as well as capable of peptide binding and protection, 91 
as demonstrated for hyaluronate/PROT systems (Umerska et al., 2014), however key 92 
parameters determining their pharmaceutical suitability (such as optimum conditions of 93 
formation and stability) first need to be assessed.  94 
 95 
2. Materials and methods 96 
2.1 Materials 97 
Iota carrageenan (IC, cat. no. C4014), kappa carrageenan (KC, cat. no. 22048), lambda 98 
carrageenan (LC, cat. no. 22049) and protamine (PROT) (as a sulphate salt, from salmon, 99 
cat. no. P4020) were obtained from Sigma-Aldrich. All other reagents and chemicals used 100 
were of analytical grade.      101 
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2.2 Preparation and characterisation of polymer and PROT solutions 102 
Loss on drying for polymers was determined by thermogravimetry. A Mettler TG 50 module 103 
linked to a Mettler MT5 balance was employed (Paluch et al., 2010). Sample weights 104 
between 10–12 mg were used, placed into open aluminium pans and heated isothermally for 105 
3h at 105 ºC under nitrogen purge.  106 
Sulphate content was measured by turbidimetry on 20 mg polymer samples hydrolysed for 107 
5h in 15 ml HCl at 105 ºC in sealed glass tubes, following the procedure of Dogson and 108 
Price (1962). Aliquots of 0.2 ml of the hydrolisates were transferred to glass tubes containing 109 
3.8 ml 3% w/v trichloroacetic acid and 1 ml of the barium chloride reagent (0.5 g barium 110 
chloride dissolved in 100 ml of 0.5% w/v gelatin solution) was added to each of the tubes. 111 
The contents were thoroughly mixed, kept at room temperature for 15-20 minutes and 112 
absorbance was measured at 360 nm against the blank. The blank consisted of 0.2 ml 1M 113 
HCl mixed with 3.8 ml 3% w/v trichloroacetic acid and 1 ml of gelatin solution. The calibration 114 
curve was made using anhydrous potassium sulphate (20-200 µg/ml sulphates). 115 
Aliquots of 100 ml of 0.1% w/v (1 mg/ml) and 0.05% w/v (0.5 mg/ml) solutions of IC, KC, LC 116 
and PROT were prepared in deionised water. LC and PROT were dispersed at 25 ºC and 117 
stirred for 30 min on a magnetic stirrer at 500 rpm until a clear solution resulted. For KC and 118 
IC, the polymers were first dissolved with vigorous stirring in deionised water at 80 ºC. When 119 
clear solutions were obtained, the polymer solutions were removed from the heat and stirred 120 
at 500 rpm for at least 30 min until the temperature reached 25 ºC. The volume of KC and IC 121 
solutions was made up to 100 ml to account for any evaporation which occurred during the 122 
heating.  123 
A low frequency vibration viscometer (SV-10 Vibro Viscometer, A&D Company Limited, 124 
Japan) was employed to measure the viscosity of polymer solutions and NP dispersions. 125 
The viscometer was calibrated with deionised water before use. Viscosity measurement of 126 
each sample was carried out in triplicate at 25±0.2 ºC. A water bath (Reciprocal Shaking 127 
Bath Model 25, Precision Scientific, UK) was used to equilibrate the samples prior to the 128 
measurement. The results are given as an average ± standard deviation (SD). 129 
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A Thermo Electron Orion 420A+ Basic pH/mV/ORP 25 ºC, Thermo Electron Corporation pH 130 
meter equipped with an Orion RoseTM 8103SC glass body pH semi-micro electrode was 131 
used to perform pH analyses. pH measurement of each sample was conducted in triplicate 132 
at 25 ºC. The pH meter was calibrated with standard buffer solutions at pH 4, 7 and 10 133 
before each batch of sample measurements. The results are given as an average value of 134 
three measurements ± SD. 135 
Gel Permeation Chromatography (GPC) measurements of the molecular weight of 136 
carrageenans were performed using a system composed of an LC-10 AT VD liquid 137 
chromatograph pump system, a SIL-10 AD VP autoinjector, a FCV-10 AL VP low pressure 138 
gradient flow-control valve, a DGU-14A degasser, a Waters 410 refractive index detector 139 
and an SCL-10A VP system controller (Shimadzu, Japan). A Plaquagel–OH mixed 8 µm, 140 
300 × 7.5 mm column (Polymer Laboratories Ltd., UK) was used. The mobile phase was 141 
composed of 0.2M NaCl and 0.01M NaH2PO4 adjusted to pH 7.4 with NaOH solution 142 
(Umerska et al., 2012). The mobile phase flow rate in each case was 1 ml/min. Pullulan 143 
standards (PL Polymer Laboratoires, Germany) were used to construct the calibration curve. 144 
Solutions of standards and samples (1 mg/ml) were prepared in the mobile phase and 100 µl 145 
of samples or standards were injected in triplicate. Shimadzu CLASS-VP software (version 146 
6.10) with GPC for Class VP (version 1.02) was used for data collection and peak 147 
integration. 148 
Fourier transform infrared spectroscopy (FTIR) of various types of carrageenans and PROT 149 
was carried out as described previously (Umerska et al., 2012). 150 
2.3 Synthesis and characterisation of NPs composed of CAR and PROT 151 
Aliquots of 0.05% and 0.1% w/v solutions of IC, KC, LC and PROT were prepared according 152 
to the method described in Section 2.2. Polymer and PROT solutions were combined 153 
together in various v/v ratios at room temperature (RT) and mixed under magnetic stirring for 154 
around 10 min to allow stabilisation of the system. Since the concentration of both 155 
components was the same, either 0.05% or 0.1% w/v, those v/v ratios were equivalent to 156 
CAR/PROT weight mixing ratios (WMRs) and WMRs are used throughout this manuscript.  157 
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Two methods of NP preparation were considered: 158 
Method_A. An aliquot of PROT solution was added to an aliquot of polymer solution under 159 
magnetic stirring. Stirring was continued for 10 minutes.  160 
Method_B. An aliquot of polymer solution was introduced to an aliquot of PROT solution 161 
under magnetic stirring. Stirring was continued for 10 minutes. 162 
To examine the impact of divalent cations on IC/PROT NPs formation, CaCl2 (final 163 
concentration of 0.05 M and 0.01 M) and ZnCl2 (final concentration of 0.01 M) were 164 
dissolved in 0.1% w/v solution of PROT. The polymer and PROT/cation solutions were 165 
combined together in various v/v ratios at room temperature and mixed under magnetic 166 
stirring for 10 minutes to allow stabilisation of the system. 167 
2.4 Physicochemical characterisation of NPs  168 
The mean particle size (hydrodynamic particle diameter) and polydispersity index (PdI) of 169 
prepared polyelectrolyte complexes were determined by dynamic light scattering (DLS) with 170 
the use of 173 degrees backscatter detection. The value of material refractive index used 171 
was 1.59, while that of absorption 0.01. Actual values of medium viscosity were input and 172 
the refractive index of dispersant was kept 1.33, the same as water. The electrophoretic 173 
mobility values measured by Laser Doppler Velocimetry (LDV) were converted to zeta 174 
potential (ZP) values using the Smoluchowski equation. Both measurements (DLS and LDV) 175 
were performed on a Zetasizer Nano ZS series Nano-ZS ZEN3600 fitted with a 633 nm laser 176 
(Malvern Instruments Ltd., UK). Samples without dilutions were placed directly into a clear 177 
plastic zeta cell (DTS 1061, Malvern, UK) and equilibrated for 2 min at 25 ºC prior to the 178 
measurement. The readings for each sample were performed at least three times and at 179 
least three batches of each sample were prepared and analysed. The results are presented 180 
as an average of size ± SD, polydispersity index (PdI) ± SD and ZP ± SD. 181 
Viscosity and pH measurements were performed in the same way as described above in 182 
Section 2.2. 183 
FTIR analysis was performed on CAR/PROT systems produced by combining 0.1% w/v 184 
solutions at a weight mixing ratio of 1 as described previously (Umerska et al., 2012). 185 
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The structural and morphological analysis of NPs was performed by transmission electron 186 
microscopy (TEM) and scanning electron microscopy (SEM). TEM was carried out with a 187 
Tecnai G2 20 TWIN microscope (FEI, USA). Samples were applied to the shiny side of the 188 
grid for 30 s and the excess of sample was removed by blotting the grid with a filter paper. 189 
Prepared samples were dried for 24h under ambient conditions. SEM was carried out with a 190 
Zeiss Supra Variable Pressure Field Emission Scanning Electron Microscope (Germany) 191 
equipped with a secondary electron detector. Liquid dispersions of NPs were directly placed 192 
onto aluminium stubs and dried for 24h in a desiccator over silica gel. Dried NPs were 193 
sputter-coated with gold under vacuum prior to the analysis. 194 
Physical (colloidal) stability of NP formulations was visually inspected immediately after 195 
preparation, prior to carrying out any measurements. The presence/absence of aggregation 196 
was recorded. The colloidal stability of NPs (in native dispersions) upon storage was 197 
determined by measuring changes in the hydrodynamic particle size, PdI and ZP over time. 198 
Measurements and visual observations were performed directly after sample preparation 199 
(day 0) and were continued every 24h for a further 3 days.  200 
The colloidal, physical stability of NPs in the following liquid media: 0.01M HCl, 0.1M acetate 201 
buffer pH 4.5, 0.1M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer pH 202 
6.5 and 0.01M phosphate buffered saline (PBS) pH 7.4 was also determined. The aqueous 203 
dispersions of NPs were diluted with a suitable medium in the 1:1 v/v ratio. The colloidal 204 
stability of the prepared NPs was determined by measuring changes in the mean 205 
hydrodynamic particle size over time. Measurements and visual observations were 206 
performed directly after sample preparation (day 0) and were continued every 24h for 207 
another 3 days.  208 
2.5 Statistical analysis 209 
The statistical significance of the differences between samples was determined by one-way 210 
analysis of variance (ANOVA) using Origin software version 7.5.  211 
 212 
3 Results and discussion 213 
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3.1 Formulation of NPs composed of various types of carrageenan and PROT 214 
3.1.1 Impact of carrageenan type and solution concentration on NP formation 215 
The molecular weight of the polymers was determined by GPC and it ranged from ~600 to 216 
~700 kDa (Table 1). It was therefore assumed that only differences in the polymer chemical 217 
composition and/or structural differences (Figure 1), but not molecular weight, may affect the 218 
NP formation. The molecular weight of the polymer is reported as a crucial parameter that 219 
determines the success of the polymeric NP formation process, as established by Boddohi, 220 
Killingsworth and Kipper (2008) and Umerska et al. (2012).  221 
Preliminary studies were first executed to examine each type of CAR for its ability to form 222 
PECs with PROT. CAR and PROT solutions (each at 1 mg/ml) were combined at various 223 
CAR/PROT WMRs using manufacturing Method_A, as previously employed by Umerska et 224 
al. (2012). The combination of IC and PROT gave the smallest particles with the lowest PdIs 225 
when compared with the KC/PROT and LC/PROT systems (Figure 2A and 2B). The particle 226 
size and PdI were seen to increase with increasing CAR/PROT WMR. Formation of large 227 
particulates, an indication of coagulation or aggregation, was observed for most of the 228 
KC/PROT WMRs tested (Figure 2A). High PdI values were measured for the KC/PROT 229 
samples with particles in the nano size range (Figure 2B). SEM analysis (Figure 3) showed 230 
the presence of NPs and not microparticles, thus it may be concluded that the appearance of 231 
large particles for some of the KC/PROT systems was symptomatic of an aggregation 232 
process rather than coagulation. NPs with particle sizes of ~100-350 nm were formed when 233 
combining LC and PROT solutions (Figure 2A). Generally, LC/PROT NPs were larger in size 234 
when the LC/PROT WMRs was lower than 1.  235 
All combinations tested: KC/PROT, IC/PROT and LC/PROT showed the formation of large 236 
entities at a WMR of 1, consistent with charge neutralisation occurring at this CAR/PROT 237 
WMR (Boddohi et al., 2008; Umerska et al., 2012). This was an interesting finding, as the 238 
different types of CAR vary in the number of sulphate residues in their structures (Figure 1) 239 
and in theory each of them should have a different, characteristic charge neutralisation point. 240 
Nevertheless, the actual sulphate content in the various CAR types varied between 20 and 241 
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27% (Table 1), which can be considered similar. Since the pKa value of the anionic sulphate 242 
group in CAR is around 2 (Gu, Decker and McClements, 2004), at pH of the CAR solution 243 
(Table 1) ionisation of the sulphate groups should be complete and all the groups will be 244 
available for potential binding with PROT.  245 
Zeta potential (ZP) values showed that the NPs can bear either negative or positive surface 246 
charge (Figure 2C). ZP of positively charged NPs had similar values for each type of NP, 247 
possibly due to the PROT presence on the surface. Negatively charged NPs composed of 248 
KC/PROT and LC/PROT had similar ZP values (around -100 mV at a CAR/PROT WMR of 3 249 
and approximately -200 mV at a CAR/PROT WMR of 5). A higher charge, around -80 - -100 250 
mV, in comparison to KC/PROT and LC/PROT, was measured for negatively charged 251 
IC/PROT NPs. NPs based on IC displayed the most promising results in terms of obtaining 252 
NPs with the smallest particle sizes and lowest PdI values (Figure 2).  253 
Thrimawithana, Young, Dunstan and Alany (2010) have characterised properties of 254 
carrageenan gels and reported the existence of both KC and IC as random coils in solution 255 
and at high temperatures. On reduction of this temperature a double-helix structure is 256 
induced to form small independent domains via intermolecular interactions between a limited 257 
number of polysaccharide chains. KC forms honeycomb-like, hard gel structures while IC 258 
forms soft, elastic gel structures (Thrimawithana et al., 2010). LC does not form gels and it is 259 
characterised by a random distribution of polymer chains in solution (Berth et al., 2008). 260 
Conformation dependent interactions of carrageenans with other polymers and drugs have 261 
been reported in the literature. Thrimawithana, Young, Bunt, Geen, and Alany (2011) 262 
highlighted that, in the coiled conformation, the sulphate groups of carrageenans are further 263 
apart (at a distance of about 1 nm) than in the helix conformation (about 0.66 nm). As such, 264 
long range intermolecular forces between the sulphate groups are weaker in the coiled 265 
formation. Therefore, the polyanionic character of carrageenans would appear more 266 
important for polyelectrolyte complexation when present in the helix form and inducing this 267 
helix conformation of CAR polymers when interacting with the polycation PROT would 268 
appear to be most desirable for NP formulation via polyelectrolyte complexation.  269 
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KC was seen as the most problematic of the polymers used in initial formulation studies 270 
using 1 mg/ml CAR solutions, with large, aggregated particles being produced at almost all 271 
KC/PROT weight ratios studied (Figure 2). A lower concentration, 0.5 mg/ml, of KC and 272 
PROT solutions was investigated and allowed the formation of particulates in the nano size 273 
range for all weight mixing ratios tested (Figure 2A). The NPs had lower PdI values ranging 274 
from 0.21 to 0.46 and greater ZP values in comparison to the NP counterparts, if formed, 275 
made of 1 mg/ml solutions. While it was possible to obtain NPs based on KC when lowering 276 
its concentration, it is important to note that previous reports in the literature have indicated 277 
that typically a greater association efficiency of the drug can be achieved when greater 278 
concentration of polymers is used in their formulation (Sarmento, Ribeiro, Veiga and 279 
Ferreira, 2006; Gupta and Karar, 2011). Thus NPs with a total polymer content of 1 mg/ml 280 
would be most desirable in terms of future studies on drug loading.  281 
Overall, the CAR conformation in solution and its solution concentration appear to be the key 282 
determinants of success when forming polyelectrolyte nanoplexes with PROT. IC showed 283 
the most promising characteristics and small, homogenous and bearing either negative or 284 
positive surface charge NPs were successfully formed at 1 mg/ml solution concentrations. 285 
Additionally, it should be noted that amines (PROT is rich in arginine moieties) can induce 286 
ionic gelation of IC (Yeo, Baek and Park, 2001). 287 
3.1.2 Impact of the preparation method on properties of NPs 288 
Polyion addition mode is known to govern properties of polyelectrolyte nanoplexes (Chen, 289 
Heitmann and Hubbe, 2003; Dragan, Mihai and Schwarz, 2006; Birch & Schiffman, 2014). In 290 
experiments described in the previous section Method_A (an aliquot of PROT solution was 291 
added to a volume of HA solution) was used. A method involving the reverse addition of 292 
components (a volume of PROT solution introduced to a volume of PROT solution), i.e. 293 
Method_B, was also tested on KC/PROT (with a total polymer content of 0.5 mg/ml) and 294 
IC/PROT (with a total polymer content of 1 mg/ml) systems.  295 
Preparation Method_A yielded NPs that were generally smaller in size and with lower PdI 296 
values in case of negatively charged NPs (a CAR/PROT WMR of 5, Figure 4A and B) than 297 
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those generated using Method_B. Also, Method_A allowed the formation of NPs at a 298 
CAR/PROT WMR of 2, while Method_B resulted in samples containing large particles at this 299 
WMR. Statistically significant differences between the size of NPs were also observed for 300 
KC/PROT and IC/PROT at CAR/PROT WMRs of 0.2 and 0.5, but it was Method_B that gave 301 
smaller NPs for IC/PROT while Method_A resulted in smaller NPs for KC/PROT (Figure 4A). 302 
The variation in the particle size and PdI was not reflected in similar changes in dynamic 303 
viscosity and ZP values (Figure 4C and D), and no general trends were discerned.  304 
Birch and Schiffman (2014) investigated the order of solution addition, when making 305 
chitosan and pectin polyelectrolyte nanoplexes. Substantial differences in particle sizes and 306 
ZP values were seen, but the mechanism rationalising the variation was not provided. 307 
Dragan et al. found that the charge neutralisation point of the complexes formed between 308 
acrylamide or methacrylate derivatives of poly(sulphonate)s and poly(quaternary amine)s 309 
was dependent on whether the titrant was the polyanion or polycation (Dragan et al., 2006). 310 
In all cases when the polycation was added to the polyanion, the molar charge ratio between 311 
the cationic and anionic species was shifted to higher values. This behaviour was explained 312 
by the charge localisation on the polycations, making them less efficient in the stabilisation of 313 
complex particles with the polyanion; thus larger in size aggregates were formed. The 314 
findings of Dragan et al. (2006) can be translated into the observed increase in the particle 315 
size of IC/PROT and KC/PROT NPs at a CAR/PROT WMP of 5 as well as KC/PROT at a 316 
CAR/PROT WMP of 0.2 and 0.5, when much larger particles, indicative of a looser structure 317 
and weaker species interactions, were formed using Method_B (Figure 4A and D). Also, 318 
Method_A permitted successful NP production at a CAR/PROT WMP of 2, while extensive 319 
aggregation was seen for Method_B.  320 
However, Method_B yielded smaller particles, and with lower ZP values, for IC/PROT WMRs 321 
of 0.2 and 0.5, in comparison to Method_A, so the supposition of lower polycation efficiency 322 
does not hold for these samples.  323 
Umerska et al. highlighted the importance of the molecular weight ratio of the polyanionic 324 
and polycationic constituents and the difference in charge density (Umerska et al., 2014). 325 
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While it was possible to prepare NPs composed of hyaluronic acid (HA, molecular weight 326 
~260 kDa) and PROT (molecular weight ~5 kDa), they were not physically stable and 327 
aggregated within hours due to the large difference in molecular weight of HA and PROT. 328 
Interestingly, the molecular weight ratio for KC/PROT is ~130 and that for IC/PROT ~140, 329 
yet physically stable NPs were formed (for stability data see Section 3.4). As IC is a much 330 
stronger polyanion than HA (Cundall, Lawton, Murray and Phillips, 1979) it is able to form 331 
stronger complexes with PROT, but strong, linear polyelectrolytes are also known to form 332 
stable, however non-stoichiometric complexes (Chen et al., 2003). The component in excess 333 
here, PROT, is expected to charge-stabilise the IC/PROT NPs.  334 
The final conclusion is that PROT can either stabilise or destabilise NPs depending on the 335 
mode of mixing and the type of carrageenan. Practically, considering the rather small 336 
differences in NP properties depending on the use of Method_A or Method_B for the 337 
positively charge particles, Method_A was selected for further experiments.  338 
3.1.3 Impact of Ca2+ and Zn2+ on NP formation 339 
Calcium ion has been widely used to crosslink negatively charged polysaccharides to aid NP 340 
formation and to promote better size distribution and polydispersity of formed (Liu, Jiao, 341 
Wang, Zhou and Zhang, 2008). As reported, Ca2+ ions favour IC gel formation while K+ ions 342 
favour KC gel formation (Thrimawithana et al., 2010). Thus the addition of divalent cations 343 
(Ca2+ and Zn2+) was tested for possible alteration of IC/PROT NPs properties.  344 
At first, Ca2+ at a concentration of 0.05M was tested. However, only micron sized particles 345 
were formed after incorporation of Ca2+ ions to the IC/PROT formulations. To further check 346 
the impact of Ca2+ concentration, the concentration was decreased to 0.01M. This decrease 347 
in the ion concentration brought the particle size of PECs which were formed back into the 348 
nano-range (Figure 5A), however PdI values were greater in comparison to those of 349 
formulations without Ca2+ (Figure 5B). To further optimise the formulation another ion was 350 
sought. The presence of Zn2+ ions at a concentration of 0.01M resulted in NPs with smaller 351 
particle sizes than those containing Ca2+ ions (Figure 5A). However, the size of NPs formed 352 
with the divalent cation addition was still larger than formulations without ions (Figures 2A 353 
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and 5A). As expected, additional cations present in formulations resulted in lowering ZP for 354 
all weight ratios tested due to reaction with the anionic sulphate groups of the polymer 355 
(Figure 5C). 356 
3.2. Characterisation of interactions between CAR and PROT 357 
FTIR spectra of the different carrageenans, PROT and NPs, along with band assignments 358 
for the NP components, are presented in Figure 6.  The identity of KC, IC and LC could be 359 
easily distinguished by the presence and location of bands of sulphate galactose and 360 
sulphate 3,6-anhydrogalactose (Figure 6). The FTIR spectra of NPs were dominated by 361 
vibrations characteristic of CAR in the 650-1400 cm-1 region with prominent amide I and II 362 
peaks of PROT appearing between 1400 and 1700 cm-1 confirming the presence of both 363 
components in the NP formulations.  364 
No new covalent bonds were created in the process of combining CAR and PROT, but shifts 365 
of some absorption bands were evident (Table 2). Interestingly, the peaks associated with 366 
sulphate and amine groups of CAR and PROT moved substantially for KC/PROT and 367 
LC/PROT systems, while, for the IC/PROT sample, only the amide I band shifted 368 
considerably and not the sulphate bands. This implies that the various CAR types may 369 
interact with PROT via different mechanisms. Large shifts in the amide I band of chitosan 370 
were observed for chitosan/HA (Umerska et al., 2012) and chitosan/KC (Li et al., 2013) 371 
systems and attributed to the formation of a polyelectrolyte complex. Therefore it appears 372 
that all types of CAR are able to electrostatically complex with PROT, and this mechanism is 373 
dominant for KC/PROT and LC/PROT systems, but another process is also likely to occur in 374 
the case of IC/PROT. Thrimawithana et al. (2011) noticed that the region between 1000 and 375 
1200 cm-1 is the most sensitive to structural changes of CAR as it shows stretching 376 
absorption bands of C-O-C and C-O bonds of the polysaccharides. There is a shift by 6 cm-1 377 
of the absorption band located at 1155 cm-1 towards higher wavenumbers for IC/PROT 378 
(shifts by 1-2 cm-1 in the opposite direction are seen for KC- and LC-/PROT), consistent with 379 
deformation of IC polysaccharide chains. As the driving force for formation of PECs is 380 
attraction of oppositely charged moieties (already discussed above) and/or an increase in 381 
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entropy when the complexation is accompanied by release of counterions (Chen et al., 382 
2003), the shift of the 1155 cm-1 band may signify that the latter mechanism is also present 383 
and contributes to the formation of small and homogenous NPs.  384 
3.3. Structure and morphology of NPs 385 
Figure 3 shows SEM images of a range of CAR/PROT NPs. It can be observed that NPs 386 
with positive surface charge (a CAR/PROT WMR of 0.33) were generally spherical in shape 387 
and well defined (KC/PROT and IC/PROT), with the exception of LC/PROT for which a 388 
rather fused mass of very small nanoparticulates with sizes of approximately 10-50 nm was 389 
observed.  It is therefore likely that data presented in Figure 2A pertains to aggregated 390 
LC/PROT NPs rather than individual particles. At a CAR/PROT WMR of 3 the particles were 391 
still approximately spherical, but a greater degree of fusion was apparent.   392 
TE micrographs (Figure 3G and 3H) show spherical and well-defined structures. There is 393 
some of the polymeric corona effect (Umerska et al., 2012) visible for the NPs. 394 
3.4 Colloidal stability of IC/PROT NPs 395 
A range of formulations with different IC/PROT WMRs and properties were chosen for 396 
colloidal stability testing, which was carried out for up to 72h at RT. A large increase in the 397 
particle size was noticed only for the positively charged NPs (IC/PROT WMRs of 0.2 and 398 
0.5, Figure 7A) with a very rapid growth in the particle size and flocculation measured for the 399 
formulation with an IC/PROT WMR of 0.5. NPs with IC/PROT WMRs of 2 and 4 showed only 400 
a small increase in the particle size upon the storage. Interestingly, the increase in the 401 
hydrodynamic size of the IC/PROT WMR of 0.5 system after 24h was not accompanied by 402 
an increase in PdI (Figure 7B). A gradual decrease in ZP values for NPs with a IC/PROT 403 
WMR of 0.5 was observed, indicative of PROT detachment (Figure 7C). The best colloidal 404 
stability was determined for NPs with WMRs of 2 and 4. 405 
NPs with a positive surface charge (IC/PROT WMRs of 0.2 and 0.5) were physically 406 
unstable and aggregated either immediately after mixing with the medium (acetate buffer 407 
pH=4.5 and PBS pH=7.4) or extensive aggregation was observed after 24h (0.01M HCl and 408 
HEPES buffer pH=6.5) (Figure 8A and B). In contrast, good colloidal stability was seen for all 409 
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negatively charged formulations (IC/PROT WMPs of 2 and 4) with relatively small variations 410 
in the particle size recorded over time (Figure 8C and D).  411 
As the component in excess charge-stabilises the PEC complex (PROT for NPs with positive 412 
surface charge and CAR for NPs with negative surface charge), its ability to remain on the 413 
surface in a range of conditions will define the colloidal stability of particles. As PROT 414 
comprises small, approximately 5 kDa fragments, this component can be easily removed 415 
from the particle surface, resulting in physical destabilisation of the system. On the other 416 
hand, CAR has approximately 100 times greater molecular weight and long, unbranched 417 
chains can form entangled structures and thus are removed with more difficultly. Moreover, 418 
the impact of the ionic strength of a medium on the binding constant is well known and 419 
mathematically presented by the “Record-Lohman” equation, which describes a double 420 
logarithmic dependence of the binding constant on the ionic strength (Record, Anderson and 421 
Lohman, 1978). Thus in electrolyte media the stability of polyelectrolyte complexes may be 422 
even further decreased, as shown in Figure 8. 423 
 424 
4. Conclusions 425 
In this study, we have demonstrated that carrageenans could be used as suitable polymers 426 
for the formation of novel NPs via polyelectrolyte complexation with PROT. The type (KC, IC 427 
or LC) and solution concentration of carrageenans used was of particular importance. When 428 
0.1% w/v solutions were used, aggregation was seen for KC/PROT, while small nanoplexes 429 
with sizes of approximately 100-150 nm were obtained for the IC/PROT combination. The 430 
addition of calcium and zinc ions to the environment during the NP formation was seen to 431 
increase the particle size and surface potential of particulates and this may be perceived as 432 
an undesirable effect. Polyelectrolyte complexation was confirmed as the mechanism of NP 433 
formation accompanied by deformation of polysaccharide chains for IC/PROT systems. 434 
Good colloidal stability was seen for NPs with negative surface charge stored as native 435 
dispersions and with media at various pH.  436 
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IC was found to be the most suitable type of CAR, forming NPs with PROT that were 437 
smallest in size and most stable. Furthermore, the ease of formulation and mild preparative 438 
conditions required for preparation of these nanoplexes make them promising candidates in 439 
terms of use as nanocarriers. Therefore it is proposed to use IC/PROT nanoplexes for 440 
further studies involving loading of bioactive compounds for the purpose of drug delivery.    441 
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Table 1 Physicochemical properties of carrageenans and their solutions studied in this work. 
KC – kappa carrageenan, IC – iota carrageenan, LC – lambda carrageenan. 
Polymer 
Molecular 
weight 
(kDa) 
Loss on 
drying 
(%) 
Sulphate 
content 
(%) 
Viscosity (mPas) 
of solution 
pH of solution 
KC 672±39 11.3±0.8 20.3±1.4 
0.05% - 3.62±0.13 
0.1% - 5.49±0.04 
0.05% - 6.7±0.1 
0.1% - 7.2±0.2 
IC 724±175 18.1±0.4 26.6±1.2 
0.05% - 2.63±0.05 
0.1% - 4.34±0.01 
0.05% - 6.3±0.0 
0.1% - 6.6±0.1 
LC 579±22 14.1±1.2 21.3±0.9 
0.05% - 4.58±0.06 
0.1% - 6.06±0.19 
0.05% - 7.2±0.2 
0.1% - 7.9±0.2 
 
 
 
Table 2 FTIR band positions (in cm-1) in carrageenans, protamine (PROT) and nanoparticle 
(NP) formulations. The number in parenthesis indicate the magnitude of the shift in cm-1, * 
indicates that the group in NP formulation shifted by at least 10 cm-1. KC – kappa 
carrageenan, IC – iota carrageenan, LC – lambda carrageenan, ν – stretching, νs,a – 
symmetric and asymmetric stretching, νa – asymmetric stretching. 
Band  KC IC LC PROT 
KC/PROT 
NPs 
IC/PROT 
NPs 
LC/PROT 
NPs 
ν(C-O,C-OH) 1037 1024 1011 - 1033 (4) 1024 (0) 1007 (3) 
νa(COC) 1157 1155 1154 - 1155 (2) 1161 (6) 1153 (1) 
νa,s(SO) 1228 1215 1219 - 1212 (16)* 1215 (0) 1209 (10)* 
νa(SO2) 1374 1373 1372 - 1363 (11)* 1375 (2) 1363 (9) 
amide II and 
NH3+ 
- - 
- 
1538 1535 (3) 1538 (0) 
1534 (4) 
amide I - - - 1633 1647 (14)* 1645 (12)* 1651 (18)* 
 
 
  
 
Figure 1. Chemical structure of kappa carrageenan (KC), iota carrageenan (IC) and lambda 
carrageenan (LC). 
 
  
  
 
 
 
Figure 2. A) Hydrodynamic particle size, B) polydispersity index (PdI) and C) zeta potential 
for NPs composed of various types of carrageenans and protamine (PROT). A – 
instantaneous aggregation, KC – kappa carrageenan, IC – iota carrageenan and LC – 
lambda carrageenan.  
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Figure 3. Electron micrographs: A) SEM of KC/PROT NPs with a WMR of 0.33, B) SEM of 
KC/PROT NPs with a WMR of 3, C) SEM of IC/PROT NPs with a WMR of 0.33, D) SEM of 
IC/PROT NPs with a WMR of 3, E) SEM of LC/PROT NPs with a WMR of 0.33, F) SEM of 
  
LC/PROT NPs with a WMR of 3, G) TEM of IC/PROT NPs with a WMR of 0.5 and H) TEM of 
IC/PROT NPs with a WMR of 4. The concentration of constituents was 1 mg/ml. WMR - 
weight mixing ratio. KC – kappa carrageenan, IC – iota carrageenan, LC – lambda 
carrageenan and PROT – protamine. 
 
 
 
Figure 4. Comparison of: A) hydrodynamic particle size and B) polydispersity index (PdI), C) 
dynamic viscosity and D) zeta potential for selected NPs composed of kappa 
carrageenan/protamine (KC/PROT, 0.05% w/v) and iota carrageenan/PROT (0.1% w/v) 
formed by the following variation in the method of preparation: Method_A: an aliquot of 
PROT solution was added to an aliquot of carrageenan solution under magnetic stirring and 
Method_B: an aliquot of carrageenan solution was introduced to an aliquot of PROT solution 
under magnetic stirring. A - instantaneous aggregation, statistical analysis: *p<0.05, 
**p<0.01, ***p<0.001. 
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Figure 5. Comparison of: A) hydrodynamic particle size, B) polydispersity index (PdI) and C) 
zeta potential values for NPs composed of iota carrageenan (IC) and protamine (PROT) 
without/with addition of calcium and zinc cations.  
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Figure 6. FTIR analysis of PROT, KC, IC, LC, KC/PROT NPs, IC/PROT NPs and LC/PROT 
NPs. Band assignment was done based on studies of Bertoluzza et al. (1983); Melo, 
Feitosa, Freitas and de Paula (2002); Nanaki, Karavas, Kalantzi and Bikiaris, (2010); 
Awotwe-Otoo et al. (2012); Arman & Quader (2012). ν – stretching, νs,a – symmetric and 
asymmetric stretching, νs – symmetric stretching, νa – asymmetric stretching and δ – bending 
vibrations. Arg – arginine, 2S,G - 2-sulphate galactose (LC only), 4S,G - 4-sulphate 
galactose (KC and IC only), 6S,G - 6-sulphate galactose (LC only) and 2S,3,6AG -  2-
sulphate 3,6-anhydrogalactose (IC only). KC – kappa carrageenan, IC – iota carrageenan, 
LC – lambda carrageenan and PROT – protamine. 
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Figure 7. Colloidal stability studies of IC/PROT nanoparticle native dispersions at room 
temperature: A) hydrodynamic particle size, B) polydispersity index (PdI) and C) zeta 
potential. WMR – weight mixing ratio, IC – iota carrageenan and PROT – protamine. 
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Figure 8. Colloidal stability studies based on monitoring hydrodynamic particle size changes 
of IC/PROT nanoparticle dispersions in media with various pH. The weight mixing ratios 
(WMRs) of IC/PROT were: A) 0.2, C) 0.5, D) 2 and F) 4. A – aggregation, IC – iota 
carrageenan and PROT – protamine, HCl – 0.01M HCl, Acetate - 0.1M acetate buffer pH 
4.5, HEPES - 0.1M HEPES buffer pH 6.5 and PBS - 0.01M PBS pH=7.4. 
 
 
HCl Acetate HEPES PBS
0
25
50
75
100
125
150
175
200
AAAA%
 o
f 
in
it
ia
l 
h
y
d
ro
d
y
n
a
m
ic
 p
a
rt
ic
le
 s
iz
e
IC/PROT, WMR=0.2
 0h - medium
 0h + medium
A)
HCl Acetate HEPES  PBS
0
25
50
75
100
125
150
175
200
AAA
%
 o
f 
in
it
ia
l 
h
y
d
ro
d
y
n
a
m
ic
 p
a
rt
ic
le
 s
iz
e
IC/PROT, WMR=0.5
 0h - medium
 0h + medium
A
B)
HCl Acetate HEPES  PBS
0
25
50
75
100
125
150
175
200
%
 o
f 
in
it
ia
l 
h
y
d
ro
d
y
n
a
m
ic
 p
a
rt
ic
le
 s
iz
e
IC/PROT, WMR=2
 0h - medium
 0h + medium
 24h + medium
 48h + medium
 72h + medium
C)
 HCl Acetate HEPES PBS
0
25
50
75
100
125
150
175
200
%
 o
f 
in
it
ia
l 
h
y
d
ro
d
y
n
a
m
ic
 p
a
rt
ic
le
 s
iz
e
IC/PROT, WMR=4
 0h - medium
 0h + medium
 24h + medium
 48h + medium
 72h + medium
D)
